Brendon Yee, PhD, professor and respiratory and sleep physician, Woolcock Institute of Medical Research, discusses the ...

Imagine repeatedly falling asleep or falling down paralyzed when laughing or startled. This is life with narcolepsy, which ...

Stifel upgraded Alkermes (ALKS) to Buy from Hold with a price target of $36, up from $25. After a deep dive on the orexin space, the firm says ...

Orexin, also known as hypocretin, is a brain hormone that helps regulate sleep. A deficiency of this hormone can cause a person to develop type 1 narcolepsy. Type 1 narcolepsy, formerly known as ...

New research links childhood adversity with later attention deficits, sleep disruptions, and specific dopamine imbalances in ...

With the potential to be a first-in-class drug, seltorexant is a potent, selective orexin-2 receptor antagonist that ...

NLS Pharmaceutics shares are moving higher on Monday after the company announced it entered into a definitive merger ...

- Paper published in the international SCI-level International Journal of Molecular Sciences (IJMS) on the 'Effects of ...

ZURICH, SWITZERLAND and NESS ZIONA, ISRAEL / ACCESSWIRE / November 4, 2024 / Ltd. (NASDAQ:NLSP) ("NLS"), a biopharmaceutical ...

Goldman Sachs lowered the firm’s price target on Alkermes (ALKS) to $30 from $32 and keeps a Buy rating on the shares. The ...

Researchers have looked at the potential roles of neurotransmitters in the brain and cerebrospinal fluid including hypocretin ...